{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001130023.2:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_001130023.2",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in alpha-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005322"
  },
  "Experiment Method": [
    {
      "Assay Method": "Live-cell imaging and mitochondrial function analysis",
      "Material used": {
        "Material Source": "Primary cortical neurons",
        "Material Name": "Overexpressing mutant A53T alpha-synuclein",
        "Description": "Primary cortical neurons overexpressing mutant A53T alpha-synuclein were used to assess mitochondrial destruction and bioenergetic deficits."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130023.2:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased mitochondrial destruction and bioenergetic deficits",
          "Result Description": "Overexpression of A53T alpha-synuclein led to significant mitochondrial fragmentation, reduced ATP production, and neuronal degeneration compared to control neurons."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control neurons without A53T mutation were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Neurons with wild-type alpha-synuclein were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Mitochondrial integrity > 80% and ATP production > 70% of control",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Mitochondrial integrity < 40% and ATP production < 30% of control",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "siRNA knockdown and overexpression experiments",
      "Material used": {
        "Material Source": "Primary cortical neurons",
        "Material Name": "siRNA targeting Parkin, Mitofusin 2, or Dynamin-related protein 1",
        "Description": "siRNA or overexpression vectors were used to manipulate Parkin, Mitofusin 2, or Dynamin-related protein 1 in neurons with A53T alpha-synuclein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130023.2:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Modulation of autophagy pathways",
          "Result Description": "Inhibition of Parkin or Dynamin-related protein 1 reduced mitochondrial degradation, while overexpression of Mitofusin 2 mitigated A53T-induced mitochondrial dysfunction."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control siRNA or empty vectors were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells without siRNA treatment were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Mitochondrial degradation rate < 20% of control",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Mitochondrial degradation rate > 60% of control",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}